Yahoo Web Search

Search results

  1. 6 days ago · Jazz Pharmaceuticals develops and commercializes medicines for people with limited or no options, such as epilepsy and biliary tract cancer. Learn more about their products, values, careers, and clinical trials.

  2. 3 days ago · Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced long-term follow-up results, including the first-ever overall survival (OS) findings, from the Phase 2b HERIZON-BTC-01 clinical trial of ...

  3. Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States.

  4. Apr 2, 2024 · Zanidatamab is a HER2-targeted bispecific antibody for previously treated HER2-positive biliary tract cancer (BTC). The company has completed the BLA submission based on data from the Phase 2b HERIZON-BTC-01 trial, which showed a high response rate and a manageable safety profile.

  5. 3 days ago · As zanidatamab awaits an FDA approval decision, Jazz Pharmaceuticals is sharing long-term phase 2b data in advanced biliary tract cancer (BTC) for the HER2-targeted bispecific antibody.. The data ...

  6. People also ask

  1. People also search for